Pierre Meulien
Overview
Explore the profile of Pierre Meulien including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mestre-Ferrandiz J, Meulien P, Ostwald D, Acha V
Front Public Health
. 2024 Oct;
12:1383107.
PMID: 39363986
Introduction: Innovative medicines and vaccines can provide direct health benefits to patients and populations by preventing, treating and curing diseases, and also drive wider socioeconomic and productivity gains. However, researching...
2.
3.
Laverty H, Meulien P
Front Med (Lausanne)
. 2019 Dec;
6:275.
PMID: 31850354
The Innovative Medicines Initiative (IMI) is a public-private partnership between the European Union and the European pharmaceutical industry. Born of the necessity to foster collaboration between different stakeholders in order...
4.
Meulien P
Stud Health Technol Inform
. 2019 Apr;
258:2.
PMID: 30942701
IMI is a large public private partnership which has committed Euro 5 Billion from the European Commission, the European Pharmaceutical sector and other partners, to enable and accelerate bringing medical...
5.
Matthiessen L, Bergstrom R, Dustdar S, Meulien P, Draghia-Akli R
Lancet
. 2016 Sep;
388(10047):865.
PMID: 27597459
No abstract available.
6.
Meulien P, Mullard A
Nat Rev Drug Discov
. 2015 Aug;
14(8):521.
PMID: 26228752
No abstract available.
7.
Manolio T, Abramowicz M, Al-Mulla F, Anderson W, Balling R, Berger A, et al.
Sci Transl Med
. 2015 Jun;
7(290):290ps13.
PMID: 26041702
Around the world, innovative genomic-medicine programs capitalize on singular capabilities arising from local health care systems, cultural or political milieus, and unusual selected risk alleles or disease burdens. Such individual...
8.
9.
Blumen M, Buchet I, Meulien P, Hausser Hauw C, Neveu H, Chabolle F
Otolaryngol Head Neck Surg
. 2009 Oct;
141(5):591-7.
PMID: 19861196
Objective: To evaluate adverse effects/postoperative complications and surgical response rate of maxillomandibular advancement for the treatment of severe obstructive sleep apnea syndrome. Study Design: Case series with chart review. Setting:...